F(ab')₂ Products

• Recombinant Anti-CD79b × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L001)
• • Targets: CD79b & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-PD-1 × Anti-CTLA-4 Bispecific Antibody (Fab₂) (FAB-L002)
• • Targets: PD-1 & CTLA-4
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-Ang2 × Anti-VEGFA Bispecific Antibody (Fab₂) (FAB-L003)
• • Targets: Ang2 & VEGFA
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD33 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L004)
• • Targets: CD33 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CLL-1 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L005)
• • Targets: CLL-1 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-Csl × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L006)
• • Targets: Csl & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-EGFR × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L007)
• • Targets: EGFR & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-BCMA × Anti-TACI Bispecific Antibody (Fab₂) (FAB-L008)
• • Targets: BCMA & TACI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-gp41 × Anti-FcαRI Bispecific Antibody (Fab₂) (FAB-L009)
• • Targets: gp41 & FcαRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CLEC12A × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L010)
• • Targets: CLEC12A & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-PD-1 × Anti-TIM-3 Bispecific Antibody (Fab₂) (FAB-L011)
• • Targets: PD-1 & TIM-3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD45 × Anti-Myosin Bispecific Antibody (Fab₂) (FAB-L012)
• • Targets: CD45 & Myosin
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-DR5 × Anti-FAP Bispecific Antibody (Fab₂) (FAB-L013)
• • Targets: DR5 & FAP
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRIII × Anti-HER2 Bispecific Antibody (Fab₂) (FAB-L014)
• • Targets: FcγRIII & HER2
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD3 × Anti-IL-2R Bispecific Antibody (Fab₂) (FAB-L015)
• • Targets: CD3 & IL-2R
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD300 × Anti-CCR3 Bispecific Antibody (Fab₂) (FAB-L016)
• • Targets: CD300 & CCR3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-HER2 Bispecific Antibody (Fab₂) (FAB-L017)
• • Targets: FcγRI & HER2
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-p97 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L019)
• • Targets: p97 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-PLAP × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L020)
• • Targets: PLAP & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-SCLC1 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L021)
• • Targets: SCLC1 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-CD30 Bispecific Antibody (Fab₂) (FAB-L022)
• • Targets: FcγRI & CD30
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CR3 × Anti-CD44 Bispecific Antibody (Fab₂) (FAB-L023)
• • Targets: CR3 & CD44
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD19 × Anti-FcαR Bispecific Antibody (F(ab')₂) (FAB-L024)
• • Targets: CD19 & FcαR
  • Type: F(ab')2
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-HER2 × Anti-FcαR Bispecific Antibody (Fab₂) (FAB-L025)
• • Targets: HER2 & FcαR
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-SLA × Anti-CEA Bispecific Antibody (Fab₂) (FAB-L026)
• • Targets: SLA & CEA
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcαRI × Anti-EGFR Bispecific Antibody (Fab₂) (FAB-L027)
• • Targets: FcαRI & EGFR
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-C. albicans × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L028)
• • Targets: C. albicans & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD15 × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L029)
• • Targets: CD15 & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD19 × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L030)
• • Targets: CD19 & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD37 × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L031)
• • Targets: CD37 & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-gp41 × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L032)
• • Targets: gp41 & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-RBCs × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L034)
• • Targets: RBCs & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-RBCs × Anti-FcγRIIA Bispecific Antibody (Fab₂) (FAB-L035)
• • Targets: RBCs & FcγRIIA
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRIII × Anti-FcγRIIB Bispecific Antibody (Fab₂) (FAB-L036)
• • Targets: FcγRIII & FcγRIIB
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-RBCs × Anti-FcγRIII Bispecific Antibody (Fab₂) (FAB-L037)
• • Targets: RBCs & FcγRIII
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD28 × Anti-FOLR1 Bispecific Antibody (Fab₂) (FAB-L038)
• • Targets: CD28 & FOLR1
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-GD2 Bispecific Antibody (Fab₂) (FAB-L039)
• • Targets: FcγRI & GD2
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcαR × Anti-HER2 Bispecific Antibody (Fab₂) (FAB-L040)
• • Targets: FcαR & HER2
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcαR × Anti-HLA class II Bispecific Antibody (Fab₂) (FAB-L041)
• • Targets: FcαR & HLA class II
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-HLA class II Bispecific Antibody (Fab₂) (FAB-L042)
• • Targets: FcγRI & HLA class II
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRII × Anti-malaria antigen Bispecific Antibody (Fab₂) (FAB-L043)
• • Targets: FcγRII & malaria antigen
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-malaria antigen Bispecific Antibody (Fab₂) (FAB-L044)
• • Targets: FcγRI & malaria antigen
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-TLR × Anti-malaria antigen Bispecific Antibody (Fab₂) (FAB-L045)
• • Targets: TLR & malaria antigen
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcαR × Anti-malaria antigen Bispecific Antibody (Fab₂) (FAB-L046)
• • Targets: FcαR & malaria antigen
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-MHC class II Bispecific Antibody (Fab₂) (FAB-L047)
• • Targets: FcγRI & MHC class II
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD28 × Anti-MUC1 Bispecific Antibody (Fab₂) (FAB-L049)
• • Targets: CD28 & MUC1
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD74 × Anti-TF Bispecific Antibody (Fab₂) (FAB-L050)
• • Targets: CD74 & TF
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CEA × Anti-TNFα Bispecific Antibody (Fab₂) (FAB-L051)
• • Targets: CEA & TNFα
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-HER2 × Anti-CA125 Bispecific Antibody (Fab₂) (FAB-L052)
• • Targets: HER2 & CA125
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-HER2 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L053)
• • Targets: HER2 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-IgE × Anti-FcγRII Bispecific Antibody (Fab₂) (FAB-L054)
• • Targets: IgE & FcγRII
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-MUC1 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L055)
• • Targets: MUC1 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-CD19 Bispecific Antibody (Fab₂) (FAB-L056)
• • Targets: FcγRI & CD19
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-EGFR × Anti-CD2 Bispecific Antibody (Fab₂) (FAB-L057)
• • Targets: EGFR & CD2
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-TCR (Vβ8 ) × Anti-CD2 Bispecific Antibody (Fab₂) (FAB-L058)
• • Targets: TCR (Vβ8 ) & CD2
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD19 × Anti-CD28 Bispecific Antibody (Fab₂) (FAB-L059)
• • Targets: CD19 & CD28
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD20 × Anti-CD28 Bispecific Antibody (Fab₂) (FAB-L060)
• • Targets: CD20 & CD28
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD44 × Anti-CD28 Bispecific Antibody (Fab₂) (FAB-L061)
• • Targets: CD44 & CD28
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-EGFR × Anti-CD28 Bispecific Antibody (Fab₂) (FAB-L062)
• • Targets: EGFR & CD28
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-EPCAM × Anti-CD28 Bispecific Antibody (Fab₂) (FAB-L063)
• • Targets: EPCAM & CD28
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD44 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L064)
• • Targets: CD44 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD8 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L065)
• • Targets: CD8 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-EPCAM × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L066)
• • Targets: EPCAM & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FOLR1 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L067)
• • Targets: FOLR1 & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRI × Anti-LDL Bispecific Antibody (Fab₂) (FAB-L068)
• • Targets: FcγRI & LDL
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-FcγRII × Anti-LDL Bispecific Antibody (Fab₂) (FAB-L069)
• • Targets: FcγRII & LDL
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-HER2 × Anti-FcγRIII Bispecific Antibody (Fab₂) (FAB-L070)
• • Targets: HER2 & FcγRIII
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-MUC1 × Anti-CD2 Bispecific Antibody (Fab₂) (FAB-L071)
• • Targets: MUC1 & CD2
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-MUC1 × Anti-CD28 Bispecific Antibody (Fab₂) (FAB-L072)
• • Targets: MUC1 & CD28
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CEA × Anti-HSG Bispecific Antibody (Fab₂) (FAB-L073)
• • Targets: CEA & HSG
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for radioimaging and radiotherapy
  Compare

• Recombinant Anti-pancreatic carcinoma antigen × Anti-HSG Bispecific Antibody (Fab₂) (FAB-L074)
• • Targets: pancreatic carcinoma antigen & HSG
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for radioimaging and radiotherapy
  Compare

• Recombinant Anti-CEA × Anti-DTPA Bispecific Antibody (Fab₂) (FAB-L075)
• • Targets: CEA & DTPA
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for radioimaging and radiotherapy
  Compare

• Recombinant Anti-CEA × Anti-nido-carboranes Bispecific Antibody (Fab₂) (FAB-L076)
• • Targets: CEA & nido-carboranes
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for therapic agent delivery
  Compare

• Recombinant Anti-CD22 × Anti-saporin Bispecific Antibody (Fab₂) (FAB-L077)
• • Targets: CD22 & saporin
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for immunotoxin delivery
  Compare

• Recombinant Anti-CD38 × Anti-saporin Bispecific Antibody (Fab₂) (FAB-L078)
• • Targets: CD38 & saporin
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for immunotoxin delivery
  Compare

• Recombinant Anti-CD37 × Anti-saporin Bispecific Antibody (Fab₂) (FAB-L079)
• • Targets: CD37 & saporin
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for immunotoxin delivery
  Compare

• Recombinant Anti-CD7 × Anti-saporin Bispecific Antibody (Fab₂) (FAB-L080)
• • Targets: CD7 & saporin
  • Type: Fab₂
  • Application: FuncS, Pretargeting system for immunotoxin delivery
  Compare

• Recombinant Anti-EpCAM × Anti-Ad fiber knob Bispecific Antibody (Fab₂) (FAB-L081)
• • Targets: EpCAM & Ad fiber knob
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-ITGAV × Anti-Ad fiber knob Bispecific Antibody (Fab₂) (FAB-L082)
• • Targets: ITGAV & Ad fiber knob
  • Type: Fab₂
  • Application: FuncS, Gene delivery in gene therapy
  Compare

• Recombinant Anti-CEA × Anti-AP Bispecific Antibody (Fab₂) (FAB-L083)
• • Targets: CEA & AP
  • Type: Fab₂
  • Application: FuncS, Immunoassay
  Compare

• Recombinant Anti-CEA × Anti-GZ (β-galactosidase) Bispecific Antibody (Fab₂) (FAB-L084)
• • Targets: CEA & GZ (β-galactosidase)
  • Type: Fab₂
  • Application: FuncS, Immunoassay
  Compare

• Recombinant Anti-7-OHC(7-hydroxycoumarin) × Anti-AP (alkaline phosphatase) Bispecific Antibody (Fab₂) (FAB-L085)
• • Targets: 7-OHC(7-hydroxycoumarin) & AP (alkaline phosphatase)
  • Type: Fab₂
  • Application: FuncS, Immunoassay
  Compare

• Recombinant Anti-RBC × Anti-Listeria Bispecific Antibody (Fab₂) (FAB-L086)
• • Targets: RBC & Listeria
  • Type: Fab₂
  • Application: FuncS, Immunoassay
  Compare

• Recombinant Anti- B cell lymphoma A20-HL Idiotype × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L087)
• • Targets: B cell lymphoma A20-HL Idiotype & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti- B cell lymphoma BCL1 Idiotype × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-L088)
• • Targets: B cell lymphoma BCL1 Idiotype & CD3
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-B cell lymphoma 38C13 Idiotype × Anti-LFA-1 Bispecific Antibody (Fab₂) (FAB-L089)
• • Targets: B cell lymphoma 38C13 Idiotype & LFA-1
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti- B cell lymphoma BCL1 Idiotype × Anti-FcγRI Bispecific Antibody (Fab₂) (FAB-L090)
• • Targets: B cell lymphoma BCL1 Idiotype & FcγRI
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-B cell lymphoma 38C13 Idiotype × Anti-CD44 Bispecific Antibody (Fab₂) (FAB-L091)
• • Targets: B cell lymphoma 38C13 Idiotype & CD44
  • Type: Fab₂
  • Application: FuncS, Promising therapeutic agent
  Compare

• Recombinant Anti-CD74 × Anti-CD22 Bi-specific T-cell engagers (BsFab) (BSAB-L023)
• • Targets: CD74 & CD22
  • Type: BsFab
  Compare

• Recombinant Anti-CD19 × Anti-CD64 Bi-specific T-cell engagers (BsFab) (BSAB-L024)
• • Targets: CD19 & CD64
  • Type: BsFab
  Compare

• Recombinant Anti-ROR1 × Anti-CD3 Bispecific Antibody (Fab₂) (FAB-LC002)
• • Targets: ROR1 & CD3
  • Type: Fab₂
  • Application: FC
  Compare

• Recombinant Mouse Anti-CD300A × Mouse Anti-IGHE Bispecific Antibody (Fab₂) (FAB-LC003)
• • Targets: CD300A & IgE
  • Type: Fab₂
  • Application: FC
  Compare

• Recombinant Anti-Cd300a × Anti-IGHE Bispecific Antibody (Fab₂) (FAB-LC004)
• • Targets: CD300A & IgE
  • Type: Fab₂
  • Application: FC
  Compare

• Recombinant Anti-D-DT × Anti-MIF Bispecific Antibody (Fab₂, MOR014093) (FAB-MZ005)
• • Targets: D-DT & MIF
  • Type: Fab₂
  • Application: ELISA
  Compare

• Recombinant Anti-HER2 × Anti-VEGF Bispecific Antibody (F(ab`)2, bH1-44) (FAB-MZ006)
• • Targets: HER2 & VEGF
  • Type: F(ab')2
  • Application: FC
  Compare

• Recombinant Anti-EGFR × Anti-ErbB-3 Bispecific Antibody (Fab₂, PB4522) (FAB-MZ007)
• • Targets: EGFR & ErbB-3
  • Type: Fab₂
  • Application: FC, ADCC Reporter Bioassay
  Compare